Testing Ultimaster stents in everyday patient care
Part of Heart & circulation clinical trials.
This trial looks at how safe and effective two specific stents are when doctors use them as part of routine care. You may be a candidate if you’re an adult receiving one of these Ultimaster stents and can follow the study check-in schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 19 years old
- Be getting an Ultimaster Tansei stent and/or an Ultimaster Nagomi stent
- Agree to the study plan and attend required follow-up visits
- Sign informed consent (you or your guardian)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how safe and effective two types of heart stents (Synergy XD and Synergy Megatron) are after they are placed. You might consider it if you’re an adult getting one of these stents and can follow required clinic visits.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new long stent (Ultimaster Nagomi) for treating long blockages in the heart arteries. It aims to see how well the stent works in real-world patients who need a single stent for a long lesion.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This trial tests a new stent (a small mesh tube placed in your heart artery to keep it open) called MiStent II. The stent slowly releases a medicine to help prevent the artery from narrowing again. If you have coronary artery disease and need a stent, this study may help improve your treatment.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.